Carbon dioxide laser treatment for lentigo maligna: A retrospective review comparing 3 different treatment modalities

Archives of Facial Plastic Surgery

Volumn 13, Issue 6, 2011, Pages 398-403

  Lee, Haemi ^a   Sowerby, Leigh J ^a   Temple, Claire L ^a   Yu, Edward ^a,b,d   Moore, Corey C ^a,c,d  

^a Department of Surgery ^*  (Canada)

^b Division of Radiation Oncology   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d Regional Cancer Program   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHEMOSURGERY; COMPARATIVE STUDY; FEMALE; HUMAN; LASER; MALE; MALIGNANT LENTIGO; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RETROSPECTIVE STUDY; SKIN TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; LASERS, GAS; MALE; MIDDLE AGED; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84863230267     PISSN: 15212491     EISSN: 15383660     Source Type: Journal    
DOI: 10.1001/archfacial.2011.66     Document Type: Article

References (25)

1. Zalaudek I, Horn M, Richtig E, Hödl S, Kerl H, Smolle J. Local recurrence in melanoma in situ: influence of sex, age, site of involvement and therapeutic modalities. Br J Dermatol. 2003;148(4):703-708. (Pubitemid 36629748)
2. Koh HK, Michalik E, Sober AJ, et al. Lentigo maligna melanoma has no better prognosis than other types of melanoma. J Clin Oncol. 1984;2(9):994-1001. (Pubitemid 14026255)
3. Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol. 1987;116(3):303-310. (Pubitemid 17030533)
4. Hazan C, Dusza SW, Delgado R, Busam KJ, Halpern AC, Nehal KS. Staged excision for lentigo maligna and lentigo maligna melanoma: a retrospective analysis of 117 cases. J Am Acad Dermatol. 2008;58(1):142-148. (Pubitemid 350298149)
5. Cohen LM, McCall MW, Zax RH. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma: a follow-up study. Dermatol Surg. 1998;24(6):673-677. (Pubitemid 28294414)
6. Zitelli JA, Brown CD, Hanusa BH. Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol. 1997;37(3, pt 1):422-429. (Pubitemid 27430641)
7. Coleman WP III, Davis RS, Reed RJ, Krementz ET. Treatment of lentigo maligna and lentigo maligna melanoma. J Dermatol Surg Oncol. 1980;6(6):476-479. (Pubitemid 10073530)
8. Osborne JE, Hutchinson PE. A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. Br J Plast Surg. 2002;55(8):611-615. (Pubitemid 35469781)
9. Pitman GH, Kopf AW, Bart RS, Casson PR. Treatment of lentigo maligna and lentigo maligna melanoma. J Dermatol Surg Oncol. 1979;5(9):727-737. (Pubitemid 10240696)
10. Gaspar ZS, Dawber RP. Treatment of lentigo maligna. Australas J Dermatol. 1997;38(1):1-8. (Pubitemid 27166513)
11. Hengge UR, Schaller J. Successful treatment of invasive squamous cell carcinoma using topical imiquimod. Arch Dermatol. 2004;140(4):404-406. (Pubitemid 38469242)
12. Noel B, Kunzle N. Image in clinical medicine: lentigo maligna. N Engl J Med. 2005;353(20):2176.
13. Van Meurs T, Van Doorn R, Kirtschig G. Treatment of lentigo maligna with imiquimod cream: a long-term follow-up study of 10 patients. Dermatol Surg. 2010;36(6):853-858.
14. Agarwal-Antal N, Bowen GM, Gerwels JW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J Am Acad Dermatol. 2002;47(5):743-748. (Pubitemid 35239337)
15. Lee PK, Rosenberg CN, Tsao H, Sober AJ. Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. JAmAcad Dermatol. 1998;38(2, pt 2):314-317. (Pubitemid 28115239)
16. Orten SS, Waner M, Dinehart SM, Bardales RH, Flock ST. Q-switched neodymium: yttrium-aluminum-garnet laser treatment of lentigo maligna. Otolaryngol Head Neck Surg. 1999;120(3):296-302. (Pubitemid 29135860)
17. Kopera D. Treatment of lentigo maligna with the carbon dioxide laser. Arch Dermatol. 1995;131(6):735-736.
18. Iyer S, Goldman M. Treatment of lentigo maligna with combination laser therapy: recurrence at 8 months after initial resolution. J Cosmet Laser Ther. 2003;5(1):49-52. (Pubitemid 36626783)
19. Niiyama N, Niiyama S, Takasu H, Katsuoka K. Progression of lentigo maligna into lentigo maligna melanoma following laser treatment. Eur J Dermatol. 2007;17(3):252-253. (Pubitemid 46847799)
20. Madan V, August PJ. Lentigo maligna-outcomes of treatment with Q-switched Nd:YAG and alexandrite lasers. Dermatol Surg. 2009;35(4):607-612.
21. Kauvar A N B, Geronemus RG. Treatment of lentigo maligna with the Q-switched ruby laser [abstract]. Lasers Surg Med. 1995;7:48.
22. O'Donnell B, Dervan P, Codd M, Powell F, Lawlor D, O'Loughlin S. A clinicopathological correlation of 134 stage 1 and 79 non-invasive cutaneous melanomas presenting over a decade (1984-1993) at the Mater Misericordiae Hospital, Dublin. Ir J Med Sci. 1998;167(3):132-135. (Pubitemid 28510978)
23. van der Spek-Keijser LM, van der Rhee HJ, Tóth G, Van Westering R, Bruijn JA, Coebergh JW. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980. Br J Dermatol. 1997;136(4):565-571. (Pubitemid 27160332)
24. Farshad A, Burg G, Panizzon R, Dummer R. A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays. Br J Dermatol. 2002;146(6):1042-1046. (Pubitemid 34779486)
25. McKenna JK, Florell SR, Goldman GD, Bowen GM. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol Surg. 2006;32(4):493-504.